PDS Biotechnology

All the posts published.

PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

Jun 22, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares London, UK – 22 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), announced the closing of its…

NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction

Jun 16, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction London, UK – 16 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq: PDSB) yesterday announced an issue of c.5.3 million new shares of common stock…

PDS Biotech Announces Proposed Offering of Common Stock

Jun 15, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS Biotech Announces Proposed Offering of Common Stock   London, UK – 15 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced that it has commenced an underwritten public offering of shares of its common stock…

PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting

Jun 8, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting   London, UK – 8 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), today announced…

PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting

May 20, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting   London, UK – 20 May 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) today announced publication of…

PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results

May 13, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results   London, UK – 13 May 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) today announced an update on business, as well as financial results for the…

PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting

Apr 30, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting   London, UK – 30 April 2021 - NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) yesterday announced that initial…

PDS Biotechnology Reports Final Results for the Full Year 2020 & Business Update

Mar 18, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Biotechnology Reports Final Results for the Full Year 2020 & Business Update   London, UK – 18 March 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (“PDS”) (Nasdaq: PDSB) announced its financial results for the full year ended 31 December…

PDS COVID-19 Vaccine Commercialisation Update

Mar 11, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS COVID-19 Vaccine Commercialisation Update c. $60m Funding Commitment by Brazilian government for Clinical Development and Commercialisation of PDS Consortium’s COVID-19 Vaccine London, UK – 11 March 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that PDS Biotech’s proprietary Versamune® T-cell activating technology, today announced that its…

PDS COVID-19 Vaccine Commercialisation Update

Feb 23, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the “Group” or the "Company")   PDS COVID-19 Vaccine Commercialisation Update   Blanver joins PDS-Farmacore COVID-19 Vaccine Consortium   PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine   London, UK – 23 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that Blanver Farmoquímica…
PDS Biotechnology Archives - NetScientific